Origin of Basophils and Mast Cells  by Arinobu, Yojiro et al.
Allergology International Vol 58, No1, 2009 www.jsaweb.jp 21
Origin of Basophils and Mast Cells
Yojiro Arinobu1, Hiromi Iwasaki1 and Koichi Akashi1,2,3
ABSTRACT
Basophils and mast cells are major players in the progression of allergic disorders. Although both cell types
originate from hematopoietic stem cells, their lineage commitment pathways and mechanisms have been un-
solved issues in hematology. Recent advances in the multicolor FACS system enable the prospective isolation
of progenitor populations whose readouts are restricted to basophil andor mast cell lineages. These newly-
isolated progenitor subsets are helpful to understand the developmental machinery of basophil and mast cell
lineages, leading to the possible exploitation of a novel therapeutic strategy for allergic and autoimmune disor-
ders. In this review, we summarize the recent progress in our understanding of the basophilmast cell ontogeny
on a cellular basis.
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INTRODUCTION
It has been well established that mast cells play a piv-
otal role in allergic disorders.1 Mast cells possess the
αβγ2 form high-affinity receptor for IgE (FcεRI) and,
upon crosslinking of the FcεRI-bound IgE with biva-
lent or multivalent antigens, they release diverse pre-
formed and lipid mediators as well as cytokines, lead-
ing to the immediate hypersensitivity with local
symptoms and the sequential inflammatory process.
Recent studies demonstrated that mast cells also play
a critical role in development of autoimmune disor-
ders2,3 such as rheumatoid arthritis,4 multiple sclero-
sis,5 and systemic sclerosis.6 Thus, mast cells are
now considered to be “a linker” between innate and
acquired immunity.7
Basophils, another cell type which expresses
FcεRI, have not been a subject of intensive research
presumably because of their sparse distribution in he-
matopoietic organs, which represents less than 1% of
blood leukocytes, and of their short life span. Fur-
thermore, lack of basophil-deficient mouse models
made it difficult to explore the in vivo function of ba-
sophils. In recent years, however, we are getting a
new insight into the function of basophils in allergic
disorders. Mukai and colleagues elegantly showed
the crucial role of basophils in the development of
IgE-mediated chronic allergic inflammation by utiliz-
ing the FcεRI deficient mouse model.8,9 Basophils are
involved in a variety of immune reactions including
initiation of Th2 differentiation,10 progression of IgG-
mediated systemic anaphylaxis,11 and enhancement
of humoral immune memory responses.12 These ob-
servations collectively suggest that basophils besides
mast cells are critical immunoregulators in diverse
immune responses, and could be cellular targets to
control allergic and autoimmune disorders. Thus, un-
derstanding the developmental machinery of baso-
phils and mast cells is critical.
Both basophils and mast cells develop from hema-
topoietic stem cells. Basophils typically become ma-
ture in the bone marrow, and then enter the circula-
tion. On the other hand, mast cell precursors leave
the bone marrow before their terminal maturation,
and home vascularized peripheral tissues such as a
digestive tract where they become mature.13,14 The
origin and developmental relationships of basophils
and mast cells have long been the major unsolved is-
sue in hematology. Focusing on adult murine hema-
topiesis, this review summarizes the recent progress
in our understanding of the cellular origin and devel-
opmental mechanisms of basophilmast cell lineages.
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Fig. 1 Diferentiation pathways in adult murine hematopoiesis. Hierarchical hematopoietic developmen-
tal pathways have been proposed based on the result of prospective purification of lineage-restricted 
progenitors. (A) Conventional model. First commitment step is the strict segregation of myeloid and lym-
phoid lineages. (B and C) Alternative models that are proposed by Adolfsson et al. (B) and our group (C). 
LT-HSC, long-term hematopoietic stem cels; MPP, multipotential progenitors; CLP, common lymphoid 
progenitors; CMP, common myeloid progenitors; GMP, granulocyte/monocyte progenitors; MEP, 
megakaryocyte/erythrocyte progenitors; LMPP, lymphoid-primed multipotent progenitors; GMLP, 
granulocyte/monocyte/lymphoid progenitors.
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HIERARCHICAL LINEAGE COMMITMENT IN
ADULT MURINE HEMATOPOIESIS
The most primitive HSCs with a long-term (LT) self-
renewal potential can be purified as Thy1lo or CD34−
cells within the Lin−Sca-1+c-Kit+ (LSK) fraction.15,16
Thy1− or CD34+ LSK cells are short-term (ST)-HSCs
or multipotential progenitors (MPPs), and are capa-
ble of reconstituting multi-lineage hematopoiesis only
for ―3 months. The myeloid vs. lymphoid lineage
commitment occurs after the MPP stage. In the
myeloid pathway, common myeloid progenitors
(CMPs), granulocytemonocyte progenitors (GMPs),
and megakaryocyteerythrocyte progenitors (MEPs)
were purified within the Lin−Sca-1−c-Kit+ fraction.17 In
the lymphoid pathway, common lymphoid progeni-
tors (CLPs) were isolatable as the IL-7Rα+Lin−Sca-1
loc-Kitlo population.18 Based on the existence of these
prospectively isolatable stem and progenitor cells, the
hierarchical hematopoietic map has been established
(Fig. 1A).
However, this conventional model has been chal-
lenged by several recent studies. Adolfsson et al. re-
ported that a fraction of MPPs expressing Flt3 at a
high level mostly lacked a megakaryocyteerythroid
(MegE) potential and was largely primed for the lym-
phoid lineage.19 They claimed that MPPs might se-
quentially lose lineage potentials starting with the
MegE then the granulocytemonocyte (GM) readout
during the lymphoid lineage commitment (Fig. 1B).
More recently, our group identified precursors of
CMPs or CLPs in the MPP fraction by tracing the
transcriptional activation of GATA-1, a MegE lineage-
related transcription factor,20 and PU.1, a GMlym-
phoid transcription factor,21 respectively.22 The
GATA-1+ LSK cells were precursors of conventional
CMPs and the PU.1+ LSK cells represented the
granulocytemonocytelymphoid-restricted progeni-
tor (GMLP) activity. This new finding reconciled in-
consistency of previous models, and we have pro-
posed the revised high-resolution map of hematopoie-
tic development (Fig. 1C). In this new model, GMPs
develop from both CMPs and GMLPs. Taken to-
gether, the recent identification of these new progeni-
tor subsets led to better understanding of the early
commitment process.
ONTOGENY OF BASOPHILS AND MAST
CELLS
The developmental pathway of basophils has been
controversial.23 By utilizing colony formation assays,
several groups claimed that basophils developed
from the common progenitors for basophil and
eosinophil lineages.24,25 It was also reported that
granulocytes with the hybrid characteristics of baso-
phils and eosinophils developed from normal cord
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Fig. 2 Limiting dilution analyses of basophil and mast cel development 
from purified stem and progenitor cels. Basophils and mast cels are efi-
ciently developed in the presence of Slf, IL-3, IL-6 and IL-9 when enumer-
ated on day 7 and 21, respectively. One in 60 and 88 single GMPs give rise 
to basophils and mast cels, respectively.
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blood progenitors in vitro.26 In contrast, cells possess-
ing the ultra-structural features typical of both baso-
phils and mast cells were identified in patients with
myeloproliferative disorders.27 The monoclonal anti-
body 97A6, which recognizes ectonucleotide pyro-
phosphatasephosphodiesterase-3 (E-NPP3; CD203c),
was shown to react only with basophilmast cell line-
age cells.28 Furthermore, the existence of metachro-
matic cells with features of both basophils and mast
cells was reported in patients with asthma.29 This
controversy regarding the basophilmast celleosino-
phil development should be resolved by tracing their
developmental pathway based on prospective isola-
tion of progenitors committed for each lineage.
Mast cells reside predominantly in peripheral tis-
sues.30 Mast cell precursors leave the bone marrow
prior to completion of their maturation, migrate into
various tissues, and then differentiate into mature
functional mast cells. The limit dilution analyses or
colony formation assays demonstrated that mast cell
colony-forming cells reside within the bone marrow,
spleen, peripheral blood, mesenteric lymph node,
and gut mucosa.31,32 Rodewald et al. first identified
the committed progenitors for the mast cell lineage in
mouse fetal blood.33 This mast cell progenitor was de-
fined by the phenotype of Thy-1loc-Kithi and lacked
the expression of FcεRIα transcript. In adult murine
hematopoiesis, however, neither mast cell progeni-
tors nor basophil progenitors had been identified.
IDENTIFICATION OF BASOPHILMAST
CELL LINEAGE COMMITTED PROGENI-
TORS IN ADULT MURINE HEMATOPOIESIS
To track the basophil and mast cell potentials, the fre-
quency of basophil and mast cell readouts was esti-
mated in the culture of purified stem and progenitor
subsets (Fig. 2). HSCs and CMPs but not CLPs were
capable of generating basophils and mast cells.
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Fig. 3 Identification of basophil/mast cel commited progenitors in adult murine 
hematopoiesis. (A) The expression of β7 and T1/ST2 of GMPs (left) and clonogenic analy-
sis of β7lo GMPs (right). (B) The expression of β7 and FcγRI/II of Lin－c-Kit＋ spleen cels 
(left) and clonogenic analysis of Lin-c-Kit＋β7hi spleen cels (right).
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Downstream of CMPs, GMPs but not MEPs differen-
tiated into both lineages. These data collectively sug-
gest that the basophil and mast cell development oc-
curs along with the granulocytemonocyte but not
lymphoid or erythroid differentiation pathway.
β7-integrin is a type I transmembrane glycoprotein
expressed mainly on lymphocytes. It plays a pivotal
role in the trafficking of T cells into mucosal organs.34
Mucosal mast cells also possess β7-integrin,35 mediat-
ing the tissue specific homing of intestinal mast cell
precursors.36 Accordingly, this molecule might be
useful marker to identify the committed mast cell pro-
genitors. Galli’s group first reported the identification
of the mast cell committed progenitors (MCPs) in
adult murine bone marrow.37 They fractionated the
Lin−Sca-1−c-Kit+ bone marrow progenitors according
to the expression profile of β7-integrin and CD27 and
found that the mast cell colony forming activity was
concentrated in the β7+ fraction. This β7+ fraction was
further subdivided into the T1ST2+ and the T1ST2−
cells. β7+ T1ST2+ cells differentiated only into mast
cells. β7− CMPs and GMPs did not form mast cell
colonies, suggesting that MCPs may directly develop
from MPPs independent of the myeloid pathway. The
Origin of Basophils and Mast Cells
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Fig. 4 Proposed basophil/mast cel developmental pathway in adult murine hematopoiesis. (A) 
Chen et al. identified MCPs downstream of MPPs. (B) Our model does not fit (A) because BMCPs, 
BaPs, MCPs and EoPs are identified downstream of GMPs. BMCP, basophil/mast cel progeni
tors; BaP, basophil progenitors; MCP, mast cel progenitors; EoP, eosinophil progenitors.
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proposed developmental scheme of the mast cell line-
age based on these observations is shown in Figure 4
A.
In another report, by using two monoclonal anti-
bodies (AA4 and BGD6) raised against rat mast cell
line, immature mast cells were isolatable in adult
murine bone marrow as the AA4−BGD6+ cells. These
cells also expressed CD34, CD13, and c-Kit, but not
FcεRI.38 It is unclear whether this AA4−BGD6+ pro-
genitor overlaps with the β7+T1ST2+ population.
In our hands, a small fraction of GMPs expressed
β7-integrin at a low level39 (Fig. 3A left). The purified
β7+GMPs preferentially differentiated into basophils
and mast cells in vitro but still possessed the signifi-
cant GM potential, suggesting that this population
have not fully committed to the basophil andor mast
cell lineages39 (Fig. 3A right). As a result of our inten-
sive search for β7+ progenitors in various hema-
topoietic organs, the Lin−c-Kit+ cells expressing β7-
integrin at a high level were isolatable in the spleen39
(Fig. 3B left). Surprisingly, these β7hi spleen progeni-
tors gave rise only to basophil and mast cell colonies.
Furthermore, a significant fraction (―10 %) of them
were bipotent for the basophil and mast cell lineages
at the single cell level39 (Fig. 3B right). Thus, this
newly-isolated population in the spleen was named as
the basophilmast cell progenitor (BMCP), providing
a formal proof for a common origin of the basophil
and mast cell lineages. By using another basophil
mast cell lineage specific marker, FcεRIα, monopo-
tent progenitors for the basophil (basophil progeni-
tor;BaP) and the mast cell lineage were isolatable in
the bone marrow and the intestine, respectively.39
The BaP and MCP were defined as the Lin−CD34+
FcεRIαhic-Kit−lo and the Lin−CD34+β7hiFcεRIαlo phe-
notypes, respectively. In vitro cultures, GMPs were
capable of generating BMCPs, BaPs, and MCPs irre-
spective of the expression of β7-integrin, and BMCPs
also gave rise to BaPs and MCPs. Furthermore, the
murine eosinophil lineage-committed progenitor
(EoP) was also identified downstream of GMPs as
the Lin−CD34+IL-5Rα+c-Kitlo phenotype.40 The lineal
relationships among these progenitor populations are
schematized in Figure 4B.
TRANSCRIPTIONAL REGULATION AT THE
DIVERGING POINTS OF BASOPHIL, MAST
CELL, AND EOSINOPHIL LINEAGES DOWN-
STREAM OF GMPs
BMCPs, BaPs, MCPs, and EoPs are all derived from
GMPs (Fig. 4B). The question is how each lineage
specification is made. The numerous gene-inactiva-
Arinobu Y et al.
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Fig. 5 Schematic presentation of roles of transcription factors in lineage specification to 
basophils, mast cels, and eosinophils. Up-regulation of GATA-2 instructs GMPs to difer-
entiate into eosinophils. If GMPs down-regulate C/EBPα and up-regulate GATA-2, they be-
come BMCPs. For the basophil development, C/EBPα needs to be reactivated after 
BMCP stage, whereas the continuous suppression of C/EBPα is required for the mast cel 
diferentiation.
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tion or overexpression studies have revealed that
the antagonistic or cooperative effects of multiple
transcription factors, called a “transcription factor net-
work”, play a pivotal role in establishment of lineage
diversity.41,42
The CCAAT enhancer-binding protein α (C
EBPα) is known to be an indispensable transcription
factor for the development of GMPs,43,44 regulating
the transactivation of multiple myeloid genes such as
G-CSF receptor and myeloperoxidase.45 Along with
the basophilmast cell development downstream of
GMPs, CEBPα was expressed at the highest level in
BaPs followed by GMPs, while BMCPs and MCPs
expressed lower levels of CEBPα as compared to
GMPs.46 The depletion of CEBPα at the BMCP
stage results in their exclusive differentiation into
mast cells, whereas BMCPs overexpressing CEBPα
differentiate mainly into basophils. Furthermore,
MCPs enforced with CEBPα are reprogrammed
into basophils.39 These data collectively suggest that
the dosage of CEBPα regulates the specification of
the basophil versus mast cell lineage.
Not only “dosage” but also “order” of expression of
transcription factors might be important.46 If we com-
pare the expression profiles of transcription factors
and lineage-related genes, BaPs and EoPs display al-
most similar expression pattern.46 The question is the
molecular mechanisms of basophil or eosinophil line-
age commitment downstream of GMPs. GMPs ex-
press CEBPα but not GATA-2, which is the major
transcription factor for megakaryocyteerythrocyte
development. In contrast, MCPs express GATA-2 but
not CEBPα. GMPs with the enforced expression of
GATA-2 differentiate exclusively into eosinophils,46
whereas MCPs enforced with CEBPα generate pure
basophil colonies.39 These data led us to hypothesize
that the order of expression of CEBPα and GATA-2
should be critical for lineage specification in basophil
versus eosinophil development. CLPs transduced
with CEBPα alone generate granulocyte and mono-
cyte colonies. When CLPs are introduced with C
EBPα and then GATA-2, they give rise to eosinophil
colonies. Then, the order is switched. CLPs intro-
duced with GATA-2 generate mast cell or basophil
colonies, whereas CLPs introduced GATA-2 then C
EBPα form pure basophil colonies. Collectively,
these data show that the dosage and the order of the
expression of CEBPα and GATA-2 simply regulate
myeloid developmental programs for granulocytes
monocytes, basophils, mast cells, and eosinophils.46
The interplay of CEBPα and GATA-2 at the fate deci-
sion of these myeloid lineages is summarized in Fig-
ure 5. It still remains unclear the mechanism as to
how these key transcription factors are regulated dur-
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ing basophil, mast cell and eosinophil development.
CONCLUSION
New and unique basophil functions are now emerg-
ing. The physiological roles of basophils and mast
cells must be revised. With this view, newly-identified
murine lineage-restricted progenitors should be very
useful to understand their developmental machinery.
To apply such information in understanding human
disorders, it is critical to identify the counterpart pre-
cursor populations in human hematopoiesis. Re-
cently, Mori et al. successfully identified the human
eosinophil progenitors (hEoPs) as the Lin−CD34+
CD38+IL-3Rα+CD45RA−IL-5Rα+ phenotype.47 Similar
news in the field of basophil and mast cell biology is
awaited.
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